Pharmaceutical group ยท Italy
Zambon
A group of 11 companies with 170 medicines in 9 countries.
Group structure
11 companies in 7 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท Italy
A group of 11 companies with 170 medicines in 9 countries.
11 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 170
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEOTO 3 MG/ML GOTAS รTICAS EN SOLUCIรN3 mg ยท Gotas รณticas en soluciรณn | Ciprofloxacin | Spain | Marketed | 1997 |
| ACEOTO PLUS 3 mg/ml + 0,25 mg/ml GOTAS รTICAS EN SOLUCIรN0,25 mg + 3,49 mg ยท Gotas รณticas en soluciรณn | Fluocinolone acetonide, Ciprofloxacin | Spain | Marketed | 2002 |
| ANAURANGocce auricolari, soluzione | Polymyxin b, Neomycin, Lidocaine | Italy | Authorised | |
| ANTAXONESoluzione orale | Naltrexone | Italy | Authorised | |
| ARGYFEN | Ibuprofen | Brazil | Authorised | 2026 |
| DEZIPAR 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Memantine, Donepezil | Spain | Marketed | 2021 |
| DEZIPAR 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Memantine, Donepezil | Spain | Marketed | 2021 |
| DORZOLAMIDE HYDROCHLORIDE2% base ยท Solution/drops | Dorzolamide | United States | Marketed | 2008 |
| EMYLIFFilm orodispersibile | Riluzole | Italy | Authorised | |
| Emylif 50 mg orodispergeerbare filmOrodispergeerbare film | Riluzole | Netherlands | Authorised | 2022 |
| EMYLIF 50 MG PELICULA BUCODISPERSABLE50 mg ยท Pelicula bucodispersable | Riluzole | Spain | Marketed | 2023 |
| EPALFEN EPSGranulato per soluzione orale | Lactulose | Italy | Authorised | |
| ESPIDIDOL 400 mg COMPRIMIDOS RECUBIERTOS770 mg ยท Comprimido recubierto | Ibuprofen | Spain | Marketed | 2004 |
| ESPIDIDOL 400 mg GRANULADO PARA SOLUCION ORAL SABOR MENTA770 mg ยท Granulado para soluciรณn oral | Ibuprofen | Spain | Marketed | 2007 |
| ESPIDIFEN 400 mg GRANULADO PARA SOLUCION ORAL SABOR MENTA770 mg ยท Granulado para soluciรณn oral | Ibuprofen | Spain | Marketed | 1994 |
| ESPIDIFEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA1155 mg ยท Comprimido recubierto con pelรญcula | Ibuprofen | Spain | Authorised | 2025 |
| ESPIDIFEN 600 mg GRANULADO PARA SOLUCION ORAL SABOR ALBARICOQUE1155 mg ยท Granulado para soluciรณn oral | Ibuprofen | Spain | Marketed | 2006 |
| ESPIDIFEN 600 MG GRANULADO PARA SOLUCION ORAL SABOR COLA-LIMON600 mg ยท Granulado para soluciรณn oral | Ibuprofen | Spain | Marketed | 2016 |
| ESPIDIFEN 600 mg GRANULADO PARA SOLUCION ORAL SABOR MENTA EFG600 mg ยท Granulado para soluciรณn oral | Ibuprofen | Spain | Marketed | 2011 |
| ESPIDUAL 500 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA500 mg + 200 mg ยท Comprimido recubierto con pelรญcula | Paracetamol, Ibuprofen | Spain | Authorised | 2022 |
| FLUIMUCIL | Acetylcysteine | Brazil | Authorised | 1965 |
| FLUIMUCILSoluzione per nebulizzatore | Acetylcysteine | Italy | Authorised | |
| Fluimucil 100 mg/ml, oplossing voor inhalatiedampOplossing voor inhalatiedamp | Acetylcysteine | Netherlands | Authorised | 1974 |
| Fluimucil 20 mg/ml DrankDrank | Acetylcysteine | Netherlands | Authorised | 1997 |
| Fluimucil 200 mg Bruis, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2000 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 51 | 12 | 39 | CompaniesAll medicines |
| Spain | 51 | 48 | 3 | CompaniesAll medicines |
| Netherlands | 28 | 28 | 0 | CompaniesAll medicines |
| Italy | 24 | 24 | 0 | CompaniesAll medicines |
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Canada, France, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: ยฉ OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.